// App-Quantinova.ai

: Barriers and facilitators of a latent tuberculosis screening and treatment programme of recent migrants

Researchers

Presenter

  • Kathryn O'Brien

Principal Investigators

  • Sabina Ikram

  • Matthew Burman

  • Heinke Kunst

Medical Centers

  • Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom

  • Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved